Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Price to FCF Ratio 2007–2026
Price to free cash flow (P/FCF) ratio for Oramed Pharmaceuticals Inc. (ORMP): market cap divided by trailing twelve-month free cash flow. As of May 31, 2017 it is 23.36.
From: 02/28/2017To: 03/31/2025
Stock Price
TTM Free Cash Flow
Price to FCF
Oramed Pharmaceuticals Inc. Price to FCF Ratio — FAQ
Oramed Pharmaceuticals Inc. (ORMP) price to fcf ratio over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ORMP's price to fcf ratio history?
The chart and table above show Oramed Pharmaceuticals Inc.'s price to fcf ratio by year and by quarter, including the growth rate.